Md. Code, Health - General § 21-2A-06.1
This is the official text of Md. Code, Health - General § 21-2A-06.1, part of Maryland’s Code, Health - General — covers public health regulation.
Not legal advice. This page reproduces the official text of a government statute for reference only. Laws change, and how a statute applies depends on your specific facts. For advice about your situation, consult a licensed attorney in your state.
§21–2A–06.
Official statutory text
§21–2A–06.1.
(a) Naloxone medication data:
(1) Are confidential and privileged, and not subject to discovery, subpoena, or other means of legal compulsion in civil litigation;
(2) Are not public records; and
(3) Except as provided in subsection (b) of this section or as otherwise by law, may not be disclosed to any person.
(b) (1) The Program shall disclose naloxone medication data, in accordance with regulations adopted by the Secretary, for public health surveillance, research, analysis, public reporting, and education after redaction of all information that could identify a patient, prescriber, dispenser, or any other individual.
(2) The Secretary may require submission of an abstract explaining the scope and purpose of the research, analysis, public reporting, or education before disclosing naloxone medication data under paragraph (1) of this subsection.
(a) Naloxone medication data:
(1) Are confidential and privileged, and not subject to discovery, subpoena, or other means of legal compulsion in civil litigation;
(2) Are not public records; and
(3) Except as provided in subsection (b) of this section or as otherwise by law, may not be disclosed to any person.
(b) (1) The Program shall disclose naloxone medication data, in accordance with regulations adopted by the Secretary, for public health surveillance, research, analysis, public reporting, and education after redaction of all information that could identify a patient, prescriber, dispenser, or any other individual.
(2) The Secretary may require submission of an abstract explaining the scope and purpose of the research, analysis, public reporting, or education before disclosing naloxone medication data under paragraph (1) of this subsection.
Status: in_force · Read it on the official government site
Need a lawyer in Maryland?
Find a Maryland lawyer
About this page: Statute text is reproduced from official government publishers via the
Open US Law dataset
(Vaquill AI, snapshot v2026.08, CC BY 4.0). Primary legislative text like this is public domain under the government-edicts doctrine
(Georgia v. Public.Resource.Org, 2020). We link every section back to its official source so you can verify it independently.